Jones Soda (JSDA) 10-Q 14 Nov 24 2024 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2024	Nov. 13, 2024
Document Information [Line Items]
Entity Central Index Key	0001083522
Entity Registrant Name	JONES SODA CO
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	000-28820
Entity Incorporation, State or Country Code	WA
Entity Tax Identification Number	52-2336602
Entity Address, Address Line One	4786 1st Avenue South, Suite 103
Entity Address, City or Town	Seattle
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98134
City Area Code	206
Local Phone Number	624-3357
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		115,867,660

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 2,685	$ 3,867
Accounts receivable, net of allowance of $54 and $260, respectively	2,851	2,118
Inventory	4,773	2,392
Prefunded insurance premiums from financing	0	357
Prepaid expenses and other current assets	1,366	861
Total current assets	11,675	9,595
Other assets	71	174
Fixed assets, net of accumulated depreciation of $408 and $366, respectively	122	137
Total assets	11,868	9,906
Current liabilities:
Accounts payable	2,738	716
Accrued expenses	2,352	1,283
Insurance premium financing	0	357
Taxes payable	1	0
Total current liabilities	5,091	2,356
Total liabilities	5,091	2,356
Shareholders’ equity:
Authorized — 800,000,000 issued and outstanding shares — 115,867,660 shares and 101,258,135 shares, respectively	94,908	90,273
Accumulated other comprehensive income	271	331
Accumulated deficit	(88,402)	(83,054)
Total shareholders’ equity	6,777	7,550
Total liabilities and shareholders’ equity	$ 11,868	$ 9,906

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ / shares in Thousands	Sep. 30, 2024	Dec. 31, 2023
Accounts receivable, allowance	$ 54,000	$ 260,000
Fixed assets, accumulated depreciation	$ 408,000	$ 366,000
Common stock, no par value (in dollars per share)	$ 0	$ 0
Common stock, authorized (in shares)	800,000,000	800,000,000
Common stock, issued (in shares)	115,867,660	101,258,135
Common stock, outstanding (in shares)	115,867,660	101,258,135

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue	$ 4,211	$ 4,497	$ 16,367	$ 13,173
Cost of goods sold	3,317	3,017	11,020	8,999
Gross profit	894	1,480	5,347	4,174
Operating expenses:
Selling and marketing	1,644	1,154	5,064	3,266
General and administrative	1,867	1,270	5,636	4,234
Total operating expenses	3,511	2,424	10,700	7,500
Loss from operations	(2,617)	(944)	(5,353)	(3,326)
Interest income	7	20	18	38
Interest expense	(10)	0	(17)	0
Other income (expense), net	(3)	(2)	30	(3)
Loss before income taxes	2,623	926	5,322	3,291
Income tax expense, net	(5)	(8)	(26)	(30)
Net loss	$ (2,628)	$ (934)	$ (5,348)	$ (3,321)
Net loss per share - basic and diluted (in dollars per share)	$ (0.02)	$ (0.01)	$ (0.05)	$ (0.03)
Weighted average common shares outstanding - basic and diluted (in shares)	111,244,803	101,090,744	105,015,962	100,809,838

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net loss	$ (2,628)	$ (934)	$ (5,348)	$ (3,321)
Other comprehensive income (loss):
Foreign currency translation adjustment	7	(39)	(60)	7
Total comprehensive loss	$ (2,621)	$ (973)	$ (5,408)	$ (3,314)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Private Placement [Member] Common Stock Including Additional Paid in Capital [Member]	Private Placement [Member] AOCI Attributable to Parent [Member]	Private Placement [Member] Retained Earnings [Member]	Private Placement [Member]	Common Stock Including Additional Paid in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2022					100,263,135
Balance at Dec. 31, 2022					$ 89,680	$ 287	$ (78,200)	$ 11,767
Stock-based compensation (in shares)					1,275,000
Stock-based compensation					$ 608	0	0	608
Exercise of Pinestar Warrants (in shares)					200,000
Exercise of Pinestar Warrants					$ 9	0	0	9
Net Income (Loss) Attributable to Parent					0	0	(3,321)	(3,321)
Other comprehensive loss					$ 0	7	0	7
Shares withheld for taxes upon RSU vesting (in shares)					(480,000)
Shares withheld for taxes upon RSU vesting					$ (110)	0	0	(110)
Other comprehensive gain					$ 0	7	0	7
Balance (in shares) at Sep. 30, 2023					101,258,135
Balance at Sep. 30, 2023					$ 90,187	294	(81,521)	8,960
Balance (in shares) at Dec. 31, 2022					100,263,135
Balance at Dec. 31, 2022					$ 89,680	287	(78,200)	$ 11,767
Balance (in shares) at Dec. 31, 2023					101,258,135			101,258,135
Balance at Dec. 31, 2023					$ 90,273	331	(83,054)	$ 7,550
Balance (in shares) at Jun. 30, 2023					101,058,135
Balance at Jun. 30, 2023					$ 90,110	333	(80,587)	9,856
Stock-based compensation (in shares)					0
Stock-based compensation					$ 68	0	0	68
Exercise of Pinestar Warrants (in shares)					200,000
Exercise of Pinestar Warrants					$ 9	0	0	9
Net Income (Loss) Attributable to Parent					0	0	(934)	(934)
Other comprehensive loss					0	(39)	0	(39)
Other comprehensive gain					$ 0	(39)	0	(39)
Balance (in shares) at Sep. 30, 2023					101,258,135
Balance at Sep. 30, 2023					$ 90,187	294	(81,521)	$ 8,960
Balance (in shares) at Dec. 31, 2023					101,258,135			101,258,135
Balance at Dec. 31, 2023					$ 90,273	331	(83,054)	$ 7,550
Stock-based compensation (in shares)					2,698,467
Stock-based compensation					$ 986	0	0	986
Exercise of Pinestar Warrants (in shares)					974,808
Exercise of Pinestar Warrants					$ 44	0	0	44
Net Income (Loss) Attributable to Parent					0	0	(5,348)	(5,348)
Other comprehensive loss					$ 0	(60)	0	(60)
Shares withheld for taxes upon RSU vesting (in shares)					(210,000)
Shares withheld for taxes upon RSU vesting					$ (93)	0	0	(93)
Private Placement Offering (in shares)	11,010,000
Private Placement Offering	$ 3,661	$ 0	$ 0	$ 3,661
Other comprehensive gain					$ 0	(60)	0	$ (60)
Exercise of Stock Options (in shares)					136,250			136,250
Exercise of Stock Options					$ 37	0	0	$ 37
Balance (in shares) at Sep. 30, 2024					115,867,660			115,867,660
Balance at Sep. 30, 2024					$ 94,908	271	(88,402)	$ 6,777
Balance (in shares) at Jun. 30, 2024					103,768,173
Balance at Jun. 30, 2024					$ 90,973	264	(85,774)	5,463
Stock-based compensation (in shares)					1,299,487
Stock-based compensation					$ 367	0	0	367
Net Income (Loss) Attributable to Parent					0	0	(2,628)	(2,628)
Other comprehensive loss					$ 0	7	0	7
Shares withheld for taxes upon RSU vesting (in shares)					(210,000)
Shares withheld for taxes upon RSU vesting					$ (93)	0	0	(93)
Private Placement Offering (in shares)	11,010,000
Private Placement Offering	$ 3,661	$ 0	$ 0	$ 3,661
Other comprehensive gain					$ 0	7	0	$ 7
Balance (in shares) at Sep. 30, 2024					115,867,660			115,867,660
Balance at Sep. 30, 2024					$ 94,908	$ 271	$ (88,402)	$ 6,777

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
OPERATING ACTIVITIES:
Net loss	$ (5,348,000)	$ (3,321,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	41,000	45,000
Stock-based compensation	986,000	608,000
Change in allowance for credit losses	(206,000)	40,000
Changes in operating assets and liabilities:
Accounts receivable	(542,000)	277,000
Inventory	(2,390,000)	(27,000)
Prefunded insurance premiums from financing	357,000	612,000
Prepaid expenses and other current assets	(505,000)	(506,000)
Other assets	103,000	0
Accounts payable	2,024,000	(30,000)
Accrued expenses	1,071,000	237,000
Taxes payable	2,000	(7,000)
Net cash used in operating activities	(4,407,000)	(2,072,000)
INVESTING ACTIVITIES:
Purchase of fixed assets	(27,000)	(73,000)
Net cash used in investing activities	(27,000)	(73,000)
FINANCING ACTIVITIES:
Proceeds from the exercise of Pinestar Warrants	44,000	9,000
Proceeds from the exercise of stock options	37,000	0
Net Proceeds from Private Placement Offering	3,661,000	0
Repayments on insurance financing	(357,000)	(612,000)
Net cash provided by (used in) financing activities	3,292,000	(603,000)
Net change in cash and cash equivalents	(1,142,000)	(2,748,000)
Effect of exchange rate changes on cash	(40,000)	(2,000)
Cash and cash equivalents, beginning of period	3,867,000	7,971,000
Cash and cash equivalents, end of period	2,685,000	5,221,000
Supplemental disclosure:
Income taxes	21,000	28,000
Interest	17,000	0
Restricted Stock Units (RSUs) [Member]
FINANCING ACTIVITIES:
Payment of taxes on RSU withholding	$ (93,000)	$ 0

Note 1 - Nature of Operations a

Note 1 - Nature of Operations and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Significant Accounting Policies [Text Block]	1. Nature of Operations and Summary of Significant Accounting Policies Jones Soda Co. develops, produces, markets and distributes premium beverages which it sells and distributes primarily in the United States and Canada through its network of independent distributors and directly to its national and regional retail accounts. We are a Washington corporation and have nine Basis of presentation, consolidation and use of estimates The accompanying condensed consolidated balance sheet as of December 31, 2023, September 30, 2024, In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all material adjustments, consisting only of those of a normal and recurring nature, considered necessary for a fair presentation of our financial position, results of operations and cash flows at the dates and for the periods presented. Preparing financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. Significant items subject to such estimates and assumptions include, but are not not 10 December 31, 2023. Liquidity As of September 30, 2024 December 31, 2023, nine September 30, 2024 2023 nine September 30, 2024 nine September 30, 2023. September 30, 2024 December 31, 2023. For the nine September 30, 2024, 3. nine September 30, 2023, We have experienced recurring losses from operations and negative cash flows from operating activities. These factors initially raised substantial doubt regarding the Company’s ability to continue as a going concern. On May 17, 2024, 7 September 30, 2024 $3.7 3 Based on management's current operating plan, the Company believes its cash and cash equivalents on hand, projected cash generated from product sales, proceeds from Private Placement, and funds available from the revolving credit facility are sufficient to fund the Company's operations for a period of at least 12 During the nine September 30, 2024 2023, nil, may may Revenue recognition Our contracts have a single performance obligation which is satisfied at the point in time when the customer has title and the significant risks and rewards of ownership of the product. Title and the significant risk and rewards of ownership are deemed to transfer when products are loaded onto a truck for shipment or Free on Board (“FOB”) shipping point. We primarily receive fixed consideration for sales of product, subject to adjustment as described below. Shipping and handling amounts paid by customers are primarily for online orders, and are included in revenue, and totaled $22,000 and $38,000 for the three September 30, 2024 2023, nine September 30, 2024 2023, See Note 1, 12/31/2023 10 April 1, 2024 Revenue is recorded net of provisions for discounts, slotting fees payable by us to retailers to stock our products and promotional allowances. Discounts, slotting fees and promotional allowances vary the consideration we are entitled to in exchange for the sale of products to distributors. We estimate these discounts, slotting fees and promotional allowances in the same period that the revenue is recognized for product sales to customers. These estimates are based on contract terms and our historical experience with similar programs and require management judgement with respect to estimating customer participation and performance levels. Differences between estimated expense and actual costs are normally insignificant and are recognized in earnings in the period such differences are determined. The amount of revenue recognized represents the amount that will not September 30, 2024 2023, nine September 30, 2024 2023, All sales to distributors and customers are generally final. In limited instances we may not 30 15 September 30, 2024 2023, The accounts receivable balance primarily includes balances from trades sales to distributors and retail customers. The allowance for credit losses is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance for credit losses based primarily on current trends and estimates. The Company reserves a percentage of trade receivable balances based on collection history and current economic trends that the Company expects will impact the level of credit losses over the life of the receivables. These reserves are re-evaluated on a regular basis and adjusted as needed. Account balances that are deemed uncollectible are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Allowances for credit losses of $54,000 and $260,000 as of September 30, 2024 December 31, 2023, No three nine September 30, 2024 December 31, 2023. As of September 30, 2024 December 31, 2023, no Net loss per share Basic net loss per share is computed using the weighted average number of common shares outstanding during the periods. Diluted earnings per share is computed by adjusting the weighted average number of common shares by the effective net exercise or conversion of all dilutive securities. Due to the net loss during the three nine September 30, 2024 2023, Recently adopted accounting pronouncements In June 2016, 2016 13, 2016 13” first 2023, no September 30, 2024 December 31, 2023. Recent accounting pronouncements In June 2023, 2023 07, 2023 07 December 15, 2023 ( 2024 December 15, 2024. 2023 07 Management is currently evaluating the impact of ASU 2023 07 not 2024 December 15, 2024), not

Note 2 - Inventory

Note 2 - Inventory	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	2. Inventory Inventory consisted of the following (in thousands): September 30, 2024 December 31, 2023 Finished goods $ 3,196 $ 1,380 Raw materials 1,577 1,012 $ 4,773 $ 2,392 Finished goods primarily include product ready for shipment, as well as promotional merchandise held for sale. Raw materials primarily include ingredients, concentrate and packaging. For the three September 30, 2024 2023, nine September 30, 2024 2023,

Note 3 - Shareholders' Equity

Note 3 - Shareholders' Equity	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Equity [Text Block]	3. Shareholders Equity On May 16, 2022, 2022 "2022 2011 2022 2022 2011 2011 2022 1,936,074 shares of common stock reserved under the terms of our 2011 “2011 2022 2022 2022 first first January 1 2022 January 1 ten 2022 Under the terms of the 2022 may ten September 30, 2024, 2022 (a) Stock options: A summary of our stock option activity is as follows: Outstanding Options Number of Shares Weighted Average Exercise Price (Per Share) Balance at January 1, 2024 11,407,772 $ 0.26 Options granted 2,200,000 0.24 Options exercised (136,250 ) 0.27 Options forfeited/expired (1,451,875 ) 0.29 Balance at September 30, 2024 12,019,647 $ 0.25 Exercisable, September 30, 2024 5,676,126 $ 0.27 Vested and expected to vest 11,392,535 $ 0.25 Outstanding Options Number of Shares Weighted Average Exercise Price Balance at January 1, 2023 3,369,332 $ 0.41 Options granted 9,659,000 0.23 Options forfeited/expired (1,461,185 ) 0.37 Balance at September 30, 2023 11,567,147 $ 0.26 Exercisable, September 30, 2023 3,730,065 $ 0.33 Vested and expected to vest 9,713,264 $ 0.27 (b) Restricted stock awards: In May 2023, three In 2024, five five January 1, 2024. 2024; 2024. June 30, 2024, September 30, 2024, December 31, 2024. A summary of our restricted stock activity for the nine September 30, 2024 Restricted Shares Weighted-Average Grant Date Fair Value per share Weighted-Average Contractual Life (years) Non-vested restricted stock at January 1, 2024 600,000 $ 0.26 - Granted 2,797,959 0.14 Vested (2,698,467 ) 0.16 Cancelled/expired - - Non-vested restricted stock at September 30, 2024 699,492 $ 0.14 9.3 (c) Stock-based compensation expense: Stock-based compensation expense is recognized using the straight-line attribution method over the employees’ requisite service period, or the non-employee's service period based on the term of the contract. We recognize compensation expense for only the portion of stock options or restricted stock expected to vest. Therefore, we apply estimated forfeiture rates that are derived from historical employee attrition. If the actual number of forfeitures differs from those estimated by management, additional adjustments to stock-based compensation expense may At September 30, 2024, The following table summarizes the stock-based compensation expense (in thousands): Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Stock options $ 175 $ 68 $ 523 $ 399 Warrants 18 - 18 - Common stock award - - - 17 Restricted stock 174 - 445 192 $ 367 $ 68 $ 986 $ 608 Income statement account: Selling and marketing $ 31 $ (20 ) $ 83 $ 25 General and administrative 336 88 903 583 $ 367 $ 68 $ 986 $ 608 In 2023, 2022 We employ the following key weighted-average assumptions in determining the fair value of stock options, using the Black-Scholes option pricing model and the simplified method to estimate the expected term of “plain vanilla” options: Nine months ended September 30, 2024 2023 Expected dividend yield — — Expected stock price volatility 89.3 % 87.5 % Risk-free interest rate 4.2 % 3.9 % Expected term (in years) 5.9 5.8 Weighted-average grant date fair-value 0.18 0.17 The aggregate intrinsic value of stock options outstanding at September 30, 2024 nine September 30, 2024 (d) Closing of the Pinestar Gold Inc. - Plan of Arrangement: On February 15, 2022, one one In connection with the Plan of Arrangement, Pinestar completed a subscription receipt offering for aggregate net proceeds of $7,152,000, at a price per subscription receipt equal to $0.50. As part of the closing of the Plan of Arrangement, each such subscription receipt automatically converted into one one 1:1 The issuance of shares of our common stock to the holders of Pinestar Shares (including Pinestar Shares received upon the conversion of the subscription receipts issued in the Pinestar subscription receipt offering) in the Plan of Arrangement was exempt from the registration requirements under the United States Securities Act of 1933, 3 10 one There are no outstanding warrants as of September 30, 2024. (e) Private Placement Offering: The Company issued 7,535,000 units (“Units”) on July 26, 2024, July 31, 2024, August 21, 2024 one‐half one 24 30 five may In connection with the offering, the Company paid Dominari Securities LLC (“Dominari”), who acted as exclusive placement agent for the offering, an aggregate of $166,158.40 in cash commission, representing 4.0% of the aggregate gross proceeds raised in the offering, and issued to Dominari an aggregate of 440,400 warrants as compensation for Dominari’s services. The Units were offered and sold in the offering: (i) in the United States to accredited investors in reliance on Rule 506 In connection with the issuance of the Units, the Company signed a registration rights agreement with each of the purchasers of the Units. Pursuant to the terms of this registration rights agreement, the Company is required to file a registration statement with the SEC within 30 July 26, 2024, may 1 August 23, 2024, August 30, 2024. There were 5,945,400 warrants outstanding as of September 30, 2024.

Note 4 - Segment Information

Note 4 - Segment Information	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	4. Segment Information We have one Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Revenue: United States $ 3,585 $ 3,464 $ 13,192 $ 10,507 Canada 626 1,033 3,134 2,626 Other countries - - 41 40 Total revenue $ 4,211 $ 4,497 $ 16,367 $ 13,173 During the three September 30, 2024, none three September 30, 2023, one

Note 5 - Insurance Premium Fina

Note 5 - Insurance Premium Financing	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Insurance Disclosure [Text Block]	5. Insurance Premium Financing Effective November 15, 2023, one January 15, 2024, April 15, 2024, July 15, 2024, no Effective November 15, 2022, one January 15, 2023, April 15, 2023, July 15, 2023, no

Note 6 - Line of Credit

Note 6 - Line of Credit	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	6. Line of Credit On May 17, 2024, one may first may may not three three As of September 30, 2024,

Note 7 - Commitments and Contin

Note 7 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	7. Commitments and Contingencies On March 25, 2024, August 24, 2023 ( 9 February 1, 2024, April 16, 2024, two no MJM is also seeking from P3 “P3” P3 P3. P3.

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Insider Trading Arr Line Items
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of presentation, consolidation and use of estimates The accompanying condensed consolidated balance sheet as of December 31, 2023, September 30, 2024, In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all material adjustments, consisting only of those of a normal and recurring nature, considered necessary for a fair presentation of our financial position, results of operations and cash flows at the dates and for the periods presented. Preparing financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. Significant items subject to such estimates and assumptions include, but are not not 10 December 31, 2023.
Going Concern [Policy Text Block]	Liquidity As of September 30, 2024 December 31, 2023, nine September 30, 2024 2023 nine September 30, 2024 nine September 30, 2023. September 30, 2024 December 31, 2023. For the nine September 30, 2024, 3. nine September 30, 2023, We have experienced recurring losses from operations and negative cash flows from operating activities. These factors initially raised substantial doubt regarding the Company’s ability to continue as a going concern. On May 17, 2024, 7 September 30, 2024 $3.7 3 Based on management's current operating plan, the Company believes its cash and cash equivalents on hand, projected cash generated from product sales, proceeds from Private Placement, and funds available from the revolving credit facility are sufficient to fund the Company's operations for a period of at least 12 During the nine September 30, 2024 2023, nil, may may
Revenue from Contract with Customer [Policy Text Block]	Revenue recognition Our contracts have a single performance obligation which is satisfied at the point in time when the customer has title and the significant risks and rewards of ownership of the product. Title and the significant risk and rewards of ownership are deemed to transfer when products are loaded onto a truck for shipment or Free on Board (“FOB”) shipping point. We primarily receive fixed consideration for sales of product, subject to adjustment as described below. Shipping and handling amounts paid by customers are primarily for online orders, and are included in revenue, and totaled $22,000 and $38,000 for the three September 30, 2024 2023, nine September 30, 2024 2023, See Note 1, 12/31/2023 10 April 1, 2024 Revenue is recorded net of provisions for discounts, slotting fees payable by us to retailers to stock our products and promotional allowances. Discounts, slotting fees and promotional allowances vary the consideration we are entitled to in exchange for the sale of products to distributors. We estimate these discounts, slotting fees and promotional allowances in the same period that the revenue is recognized for product sales to customers. These estimates are based on contract terms and our historical experience with similar programs and require management judgement with respect to estimating customer participation and performance levels. Differences between estimated expense and actual costs are normally insignificant and are recognized in earnings in the period such differences are determined. The amount of revenue recognized represents the amount that will not September 30, 2024 2023, nine September 30, 2024 2023, All sales to distributors and customers are generally final. In limited instances we may not 30 15 September 30, 2024 2023, The accounts receivable balance primarily includes balances from trades sales to distributors and retail customers. The allowance for credit losses is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance for credit losses based primarily on current trends and estimates. The Company reserves a percentage of trade receivable balances based on collection history and current economic trends that the Company expects will impact the level of credit losses over the life of the receivables. These reserves are re-evaluated on a regular basis and adjusted as needed. Account balances that are deemed uncollectible are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Allowances for credit losses of $54,000 and $260,000 as of September 30, 2024 December 31, 2023, No three nine September 30, 2024 December 31, 2023. As of September 30, 2024 December 31, 2023, no
Earnings Per Share, Policy [Policy Text Block]	Net loss per share Basic net loss per share is computed using the weighted average number of common shares outstanding during the periods. Diluted earnings per share is computed by adjusting the weighted average number of common shares by the effective net exercise or conversion of all dilutive securities. Due to the net loss during the three nine September 30, 2024 2023,
New Accounting Pronouncements, Policy [Policy Text Block]	Recently adopted accounting pronouncements In June 2016, 2016 13, 2016 13” first 2023, no September 30, 2024 December 31, 2023. Recent accounting pronouncements In June 2023, 2023 07, 2023 07 December 15, 2023 ( 2024 December 15, 2024. 2023 07 Management is currently evaluating the impact of ASU 2023 07 not 2024 December 15, 2024), not

Note 2 - Inventory (Tables)

Note 2 - Inventory (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, 2024 December 31, 2023 Finished goods $ 3,196 $ 1,380 Raw materials 1,577 1,012 $ 4,773 $ 2,392

Note 3 - Shareholders' Equity (

Note 3 - Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Outstanding Options Number of Shares Weighted Average Exercise Price (Per Share) Balance at January 1, 2024 11,407,772 $ 0.26 Options granted 2,200,000 0.24 Options exercised (136,250 ) 0.27 Options forfeited/expired (1,451,875 ) 0.29 Balance at September 30, 2024 12,019,647 $ 0.25 Exercisable, September 30, 2024 5,676,126 $ 0.27 Vested and expected to vest 11,392,535 $ 0.25 Outstanding Options Number of Shares Weighted Average Exercise Price Balance at January 1, 2023 3,369,332 $ 0.41 Options granted 9,659,000 0.23 Options forfeited/expired (1,461,185 ) 0.37 Balance at September 30, 2023 11,567,147 $ 0.26 Exercisable, September 30, 2023 3,730,065 $ 0.33 Vested and expected to vest 9,713,264 $ 0.27
Nonvested Restricted Stock Shares Activity [Table Text Block]	Restricted Shares Weighted-Average Grant Date Fair Value per share Weighted-Average Contractual Life (years) Non-vested restricted stock at January 1, 2024 600,000 $ 0.26 - Granted 2,797,959 0.14 Vested (2,698,467 ) 0.16 Cancelled/expired - - Non-vested restricted stock at September 30, 2024 699,492 $ 0.14 9.3
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Stock options $ 175 $ 68 $ 523 $ 399 Warrants 18 - 18 - Common stock award - - - 17 Restricted stock 174 - 445 192 $ 367 $ 68 $ 986 $ 608 Income statement account: Selling and marketing $ 31 $ (20 ) $ 83 $ 25 General and administrative 336 88 903 583 $ 367 $ 68 $ 986 $ 608
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Nine months ended September 30, 2024 2023 Expected dividend yield — — Expected stock price volatility 89.3 % 87.5 % Risk-free interest rate 4.2 % 3.9 % Expected term (in years) 5.9 5.8 Weighted-average grant date fair-value 0.18 0.17

Note 4 - Segment Information (T

Note 4 - Segment Information (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Revenue from External Customers by Geographic Areas [Table Text Block]	Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Revenue: United States $ 3,585 $ 3,464 $ 13,192 $ 10,507 Canada 626 1,033 3,134 2,626 Other countries - - 41 40 Total revenue $ 4,211 $ 4,497 $ 16,367 $ 13,173

Note 1 - Nature of Operations_2

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)	3 Months Ended		8 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($) shares	Sep. 30, 2023 USD ($) shares	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($) shares	Dec. 31, 2023 USD ($)	Jun. 30, 2024	May 17, 2024 USD ($)
Cash and Cash Equivalents, at Carrying Value	$ 2,685,000			$ 2,685,000		$ 3,867,000
Working Capital (Deficit)	6,600,000			6,600,000		7,200,000
Net Cash Provided by (Used in) Operating Activities				(4,407,000)	$ (2,072,000)
Net Income (Loss) Attributable to Parent	(2,628,000)	$ (934,000)	$ (3,300,000)	(5,348,000)	(3,321,000)
Retained Earnings (Accumulated Deficit)	(88,402,000)			(88,402,000)		(83,054,000)
Net Cash Provided by (Used in) Financing Activities				3,292,000	(603,000)
Proceeds from Stock Options Exercised				37,000	0
Revenues	4,211,000	4,497,000		16,367,000	13,173,000
Slotting Fees and Promotional Allowances	1,500,000	$ 538,000		3,100,000	$ 1,200,000
Maximum Discount for Customers, Payment Made Within 15 Days							2%
Accounts Receivable, Allowance for Credit Loss, Current	$ 54,000			$ 54,000		$ 260,000
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares	12,019,647	11,567,147		12,019,647	11,567,147
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares	5,945,400	27,521,945	27,521,945	5,945,400
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares	699,492	600,000		699,492	600,000
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Number of Major Customers				0		0
Shipping and Handling [Member]
Revenues	$ 22,000	$ 38,000		$ 101,000	$ 124,000
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity								$ 2,000,000

Note 2 - Inventory (Details Tex

Note 2 - Inventory (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Inventory Write-down	$ 82,000	$ 12,000	$ 132,000	$ 32,000

Note 2 - Inventory - Inventory

Note 2 - Inventory - Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Finished goods	$ 3,196	$ 1,380
Raw materials	1,577	1,012
Inventory, Net	$ 4,773	$ 2,392

Note 3 - Shareholders' Equity_2

Note 3 - Shareholders' Equity (Details Textual) - USD ($)			1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	May 16, 2022	Feb. 15, 2022	May 31, 2023	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2023	Aug. 21, 2024	Jul. 31, 2024	Jul. 26, 2024
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount				$ 693,000	$ 693,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)					1 year 4 months 24 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value				3,700,000	$ 3,700,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value				$ 1,500,000	1,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value					$ 15,000
Class of Warrant or Right, Outstanding (in shares)				0	0
Private Placement Units, Shares (in shares)							1,875,000	1,600,000	7,535,000
Private Placement Units, Net Proceeds				$ 3,700,000	$ 3,700,000
Warrants with Units [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)				1	1
Warrants with Units [Member] | Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 0.5	$ 0.5
Warrants with Units [Member] | Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 0.8	$ 0.8
Private Placement Warrant [Member]
Class of Warrant or Right, Outstanding (in shares)				5,945,400	5,945,400
Private Placement Warrant [Member] | Dominari Securities LLC [Member}
Payments for Commissions				$ 166,158.4
Payments for Commissions, Percentage of Aggregate Gross Proceeds Raised				4%
Class of Warrant or Right, Warrants Issued During Period (in shares)				440,400
Common Stock [Member]
Private Placement Units, Composed Shares (in shares)				1	1
Private Placement Warrant [Member]
Private Placement Units, Composed Shares (in shares)				0.5	0.5
Pinestar Subscription Receipt Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)		20,000,048
Proceeds from Issuance or Sale of Equity, Total		$ 7,152,000
Shares Issued, Price Per Share (in dollars per share)		$ 0.5
Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)			3 years
Director [Member] | Share-Based Payment Arrangement, Nonemployee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures (in shares)			300,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Granted Annual Compensation (in shares)			150,000
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage					50%
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage					25%
Restricted Stock Units (RSUs) [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage					25%
Restricted Stock Units (RSUs) [Member] | Continuing Director [Member]
Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture					$ 65,000
Restricted Stock Units (RSUs) [Member] | Non-Continuing Director [Member]
Additional Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture					$ 15,000
The 2022 Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)	10,000,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares)	11,936,074
The 2022 Incentive Plan [Member] | Common Stock Award [Member]
Stock Issued During Period, Shares, New Issues (in shares)						75,000
Stock Issued During Period, Value, New Issues						$ 17,000
The 2011 Incentive Plan [Member]
Common Stock, Capital Shares Reserved for Future Issuance (in shares)	1,936,074
Share-Based Compensation Arrangement by Share-Based Payment Award, Annual Increase, Percentage of Common Stock Shares Outstanding	4%
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)				8,138,680	8,138,680
The 2011 Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)	10 years

Note 3 - Shareholders' Equity -

Note 3 - Shareholders' Equity - Summary of Stock Option Activity (Details) - $ / shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Balance, number of shares (in shares)	11,407,772	3,369,332
Balance, weighted average exercise price (in dollars per share)	$ 0.26	$ 0.41
Options granted, number of shares (in shares)	2,200,000	9,659,000
Options granted, weighted average exercise price (in dollars per share)	$ 0.24	$ 0.23
Options exercised, number of shares (in shares)	(136,250)
Options exercised, weighted average exercise price (in dollars per share)	$ 0.27
Options forfeited/expired, number of shares (in shares)	(1,451,875)	(1,461,185)
Options forfeited/expired, weighted average exercise price (in dollars per share)	$ 0.29	$ 0.37
Balance, number of shares (in shares)	12,019,647	11,567,147
Balance, weighted average exercise price (in dollars per share)	$ 0.25	$ 0.26
Exercisable, number of shares (in shares)	5,676,126	3,730,065
Exercisable, weighted average exercise price (in dollars per share)	$ 0.27	$ 0.33
Vested and expected to vest, number of shares (in shares)	11,392,535	9,713,264
Vested and expected to vest, weighted average exercise price (in dollars per share)	$ 0.25	$ 0.27

Note 3 - Shareholders' Equity_3

Note 3 - Shareholders' Equity - Summary of Restricted Stock Activity (Details) - Restricted Stock [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Non-vested restricted stock (in shares) | shares	600,000
Non-vested restricted stock, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0.26
Granted (in shares) | shares	2,797,959
Granted, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0.14
Vested (in shares) | shares	(2,698,467)
Vested, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0.16
Cancelled/expired (in shares) | shares	0
Cancelled/expired/rescinded, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0
Non-vested restricted stock (in shares) | shares	699,492
Non-vested restricted stock, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0.14
Non-vested restricted stock, weighted-average contractual life (Year)	9 years 3 months 18 days

Note 3 - Shareholders' Equity_4

Note 3 - Shareholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Stock-based compensation expense	$ 367	$ 68	$ 986	$ 608
Selling and Marketing Expense [Member]
Stock-based compensation expense	31	(20)	83	25
General and Administrative Expense [Member]
Stock-based compensation expense	336	88	903	583
Share-Based Payment Arrangement, Option [Member]
Stock-based compensation expense	175	68	523	399
Warrant [Member]
Stock-based compensation expense	18	0	18	0
Common Stock Award [Member]
Stock-based compensation expense	0	0	0	17
Restricted Stock [Member]
Stock-based compensation expense	$ 174	$ 0	$ 445	$ 192

Note 3 - Shareholders' Equity_5

Note 3 - Shareholders' Equity - Weighted-average Assumptions (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Expected dividend yield	0%	0%
Expected stock price volatility	89.30%	87.50%
Risk-free interest rate	4.20%	3.90%
Expected term (in years) (Year)	5 years 10 months 24 days	5 years 9 months 18 days
Weighted-average grant date fair-value (in dollars per share)	$ 0.18	$ 0.17

Note 4 - Segment Information (D

Note 4 - Segment Information (Details Textual)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Number of Operating Segments	1
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers	0	1
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Concentration Risk, Percentage		19%

Note 4 - Segment Information -

Note 4 - Segment Information - Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue	$ 4,211	$ 4,497	$ 16,367	$ 13,173
UNITED STATES
Revenue	3,585	3,464	13,192	10,507
CANADA
Revenue	626	1,033	3,134	2,626
Other Countries [Member]
Revenue	$ 0	$ 0	$ 41	$ 40

Note 5 - Insurance Premium Fi_2

Note 5 - Insurance Premium Financing (Details Textual) - IPFS Corporation Insurance Agreement [Member] - USD ($)	Nov. 15, 2023	Nov. 15, 2022
Debt Instrument, Term (Year)	1 year	1 year
Debt Instrument, Face Amount	$ 357,000	$ 612,000
Short-Term Debt, Weighted Average Interest Rate, at Point in Time	8.49%	6.99%

Note 6 - Line of Credit (Detail

Note 6 - Line of Credit (Details Textual) - Revolving Credit Facility [Member]	May 17, 2024 USD ($)	Sep. 30, 2024 USD ($)
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000,000
Amerisource Funding Inc. [Member]
Number of Operating Subsidiaries	1
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000,000
Line Of Credit, Subsidiary Advances Of Eligible Accounts Receivable, Percentage	80%
Line of Credit Facility, Expiration Period (Year)	3 years
Line Of Credit, Extension Period (Year)	3 years
Line Of Credit, Termination Agreement Period (Day)	60 days
Long-Term Line of Credit		$ 0
Amerisource Funding Inc. [Member] | Minimum [Member]
Line of Credit Facility, Interest Rate On Unpaid Advances	3.50%
Amerisource Funding Inc. [Member] | Maximum [Member]
Line of Credit Facility, Interest Rate On Unpaid Advances	6%

Note 7 - Commitments and Cont_2

Note 7 - Commitments and Contingencies (Details Textual) - Pending Litigation [Member] - USD ($)		3 Months Ended
	Mar. 25, 2024	Sep. 30, 2024
Core Claim [Member]
Loss Contingency, Damages Sought, Value	$ 7,220,357
MJM v P3 Capital Partner LLC [Member]
Loss Contingency, Damages Sought, Value		$ 155,700